“…Additionally, innovative strategies are being explored for removal or neutralization of A/B antigens on cell membranes [40,41] to facilitate ABOi organ transplantation. Another approach currently under exploration in my laboratory is induction of B-cell tolerance through intentional exposure to synthetic A/B antigens in the form of implantable biomedical devices [42,43], which, if successful, would allow subsequent transplantation of grafts from donors of any blood group.…”